Sulfacarbamide

Summary

Sulfacarbamide (CHEMBL139877) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 215.23 Da · C7H9N3O3S

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL139877
Name	Sulfacarbamide
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	11033
Molecular formula	C7H9N3O3S
Molecular weight	215.23
InChIKey	WVAKABMNNSMCDK-UHFFFAOYSA-N

SMILES: C1=CC(=CC=C1N)S(=O)(=O)NC(=O)N

IUPAC name: (4-aminophenyl)sulfonylurea

Also known as: Euvernil, N-sulfanilylcarbamide, NSC-78438, Sulfacarbamida, Sulfacarbamide, Sulfanilylurea, Sulfaurea, Sulphaurea, Uractyl, Uramid, Urenil, Uromide

Patent coverage: 457 distinct patent families (1,587 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).